000 | 01797 a2200493 4500 | ||
---|---|---|---|
005 | 20250517212655.0 | ||
264 | 0 | _c20190913 | |
008 | 201909s 0 0 eng d | ||
022 | _a1872-7905 | ||
024 | 7 |
_a10.1016/j.jim.2018.04.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLayton, Erik D | |
245 | 0 | 0 |
_aValidation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination. _h[electronic resource] |
260 |
_bJournal of immunological methods _c07 2018 |
||
300 |
_a44-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntigens, Bacterial _ximmunology |
650 | 0 | 4 |
_aAntigens, CD1 _ximmunology |
650 | 0 | 4 | _aCell Culture Techniques |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
650 | 0 | 4 |
_aFlow Cytometry _xinstrumentation |
650 | 0 | 4 |
_aGlycolipids _xchemistry |
650 | 0 | 4 | _aHealthy Volunteers |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunogenicity, Vaccine |
650 | 0 | 4 |
_aLatent Tuberculosis _xdiagnosis |
650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
650 | 0 | 4 |
_aProtein Multimerization _ximmunology |
650 | 0 | 4 | _aSouth Africa |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTuberculosis Vaccines _xadministration & dosage |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aYu, Krystle K Q | |
700 | 1 | _aSmith, Malisa T | |
700 | 1 | _aScriba, Thomas J | |
700 | 1 | _aDe Rosa, Stephen C | |
700 | 1 | _aSeshadri, Chetan | |
773 | 0 |
_tJournal of immunological methods _gvol. 458 _gp. 44-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jim.2018.04.004 _zAvailable from publisher's website |
999 |
_c28315836 _d28315836 |